Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Pharmaceutics|December 11, 2024
Design and Bottom-up Production of an Aerosolizable Cannabidiol NanosuspensionLuca Casula, Michele Schlich, Maria Cristina Cardia, et al.
International Journal of Pharmaceutics|July 16, 2025
Liposomal adrenaline for cardiopulmonary resuscitation: microfluidic production and pharmacokinetic analysisAlessio Pittiu, Emanuela Locci, Giulio Ferino, et al.
International Journal of Biological Macromolecules|May 7, 2026
Alginate-based mucoadhesive nanofibrous system embedding resveratrol-loaded vesicles as a therapeutic platform for nasal disordersLuca Casula, Michele Schlich, Elena Pini, et al.
Pharmaceutics|September 28, 2023
Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin DeliveryLuca Casula, Rosa Pireddu, Maria Cristina Cardia, et al.
Journal of Colloid and Interface Science|May 18, 2024
Polyphosphoester-stabilized cubosomes encapsulating a Ru(II) complex for the photodynamic treatment of lung adenocarcinomaLuca Casula, Gina Elena Giacomazzo, Luca Conti, et al.
Pharmaceutics|January 8, 2025
Formulating a Horseradish Extract in Phospholipid Vesicles to Target the SkinMaria De Luca, Luca Casula, Carlo Ignazio Giovanni Tuberoso, et al.
Pharmaceutics|May 28, 2022
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected PairMichele Schlich, Luca Casula, Aurora Musa, et al.
International Journal of Pharmaceutics|August 6, 2022
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodentMaria Cristina Cardia, Maria Francesca Palmas, Luca Casula, et al.
International Journal of Nanomedicine|November 27, 2025
Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson's Disease Targeting α-SynucleinLuca Casula, Maria Francesca Palmas, Maria Cristina Cardia, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-MonothiopomalidomideMaria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, et al.
Pageof 3